EuroFlow™ Primary Immunodeficiency panels: a powerful tool for diagnostic patient care

Share post on social media:
EuroFlow™ Primary Immunodeficiency panels: a powerful tool for diagnostic patient care

Primary immunodeficiencies (PID) are hereditary disorders where cell types can be absent, decreased or dysfunctional. The majority of PID patients have a defect in the lymphoid system, involving B- and/or T-cells alone or in combination with other cells.

In this webinar, Tomas Kalina will explain the role of flow cytometry in the diagnostics of PID, how to perform severe combined immunodeficiency (SCID) screening by cytometry and what is the expected immunophenotypical changes in PID.

You might also like...

View blog
Capabilities of the flow cytometric OX40 assay to determine specific SARS-CoV-2 T cell responses
1 min read
Capabilities of the flow cytometric OX40 assay to determine specific SARS-CoV-2 T cell responses
The adaptive immune response to SARS-CoV-2 includes specific antibody and T cell responses. The identification of a subpopulation of...
Update on Flow Cytometry: Leukaemia and Immunotherapy
0 min read
Update on Flow Cytometry: Leukaemia and Immunotherapy
In this webinar Jordi Petriz will discuss state-of-the-art flow technology and its impact on Immunotherapy and Leukemia evaluations....
Breast Cancer & Immunohistochemistry
0 min read
Breast Cancer & Immunohistochemistry